Journal of the Korean Ophthalmological Society 2005;46(2):257-270.
Published online February 28, 2005.
Inhibitory Effects of Imatinib Mesylate on Transdifferentiation of Lens Epithelial Cells into Fibroblast.
Tea Sung Park, Jun Seok Tea, Seh Min Park, Jung Hyub Oh
1Department of Ophthalmology, Inha University, College of Medicine, Inchon, Korea. jhoh9707@hanmail.net
2Dr. Tea's Eye Clinic, Anyang, Korea.
3Incheon Medical Center, Inchon, Korea.
이마티니브 메실레이트에 의한 수정체상피세포의 섬유아세포로의 전환분화억제효과
박태성1,태준석2,박세민3,오중협1
Department of Ophthalmology, Inha University, College of Medicine1, Inchon, Korea Dr. Tea`s Eye Clinic, Anyang, Korea2, Incheon Medical Center3, Inchon, Korea
Correspondence:  Tea Sung Park, M.D.1
Abstract
PURPOSE
To investigate whether Imatinib mesylate (IM) could inhibit the transdifferentiation of the lens epithelial cells (LECs) into fibroblasts using the capsular bag model. METHODS: In the capsular bag model, LECs were cultured by exposure to IM at various concentrations for 3 min. The effect of IM was analysed by observing the covering area, numbers of alpha-SMA positive cell, and BrdU incorporated proliferating cells. The same analysis was performed in the culture of LECs with TGF-beta. RESULTS: The covering area was significantly decreased by the treatment of 30 micro M IM, and the positive cells for alpha-SMA and BrdU were also decreased by IM treatment in a dose dependent manner. In addition, increasing TGF-beta concentration accelerated transdifferentiation, but suppressed the acceleration of the transdifferentiation induced by TGF-beta. CONCLUSIONS: In the capsular bag model, IM effectively inhibited not only the transdifferentiation of LECs into fibroblasts but also the TGF-beta induced acceleration of the transdifferentiation.
Key Words: alpha-Smooth muscle actin;Capsular bag model;Fibroblast;Imatinib mesylate;Transdifferentiation


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next